The key to multiplexing is miniaturization. Instead of having just one assay in a well a whole array of miniaturized, spotted assays is analyzed simultaneously. Combining several tests brings significant savings in time and money.
The growth of private and public funding in the fields of genomics and personalized medicineis currently a high value driver for the global multiplexed diagnostics market. It is boosting the demand for advanced diagnostic technologies for precision-based diagnostics of life-threatening diseases. Current positive trends in the global multiplexed diagnostics market include the increasing rate of extensive research and development efforts being made to expand and diversify the existing applications in multiplexed diagnostics, the development in generic platforms, and a greater use of multiplexed diagnostics in academic and research organizations.
Market Analysis and Insights: Global Multiplexed Diagnostics Market
The global Multiplexed Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Multiplexed Diagnostics Scope and Market Size
Multiplexed Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Multiplexed Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Agilent Technologies
Bio-Rad Laboratories, Inc.
BioMerieux SA
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
Luminex Corporation
Hologic, Inc.
Thermo Fisher Scientific, Inc.
Siemens Healthineers
Abbott Laboratories
Multiplexed Diagnostics Breakdown Data by Type
Very High Density Multiplexed Assays (Above 10,000-plex)
High Density Multiplexed Assays (500 Below plex Below 10,000)
Medium Density Multiplexed Assays (plex Below 500)
Low Density Multiplexed Assays (plex Below 5)
Next Generation Sequencing Assays
Multiplexed Diagnostics Breakdown Data by Application
Academic Research Institutes
Hospital
Pharmaceutical Companies
Clinical Research Organizations
Diagnostic Laboratories
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Multiplexed Diagnostics Revenue
1.4 Market by Type
1.4.1 Global Multiplexed Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Very High Density Multiplexed Assays (Above 10,000-plex)
1.4.3 High Density Multiplexed Assays (500 Below plex Below 10,000)
1.4.4 Medium Density Multiplexed Assays (plex Below 500)
1.4.5 Low Density Multiplexed Assays (plex Below 5)
1.4.6 Next Generation Sequencing Assays
1.5 Market by Application
1.5.1 Global Multiplexed Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Academic Research Institutes
1.5.3 Hospital
1.5.4 Pharmaceutical Companies
1.5.5 Clinical Research Organizations
1.5.6 Diagnostic Laboratories
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Multiplexed Diagnostics Market Perspective (2015-2026)
2.2 Global Multiplexed Diagnostics Growth Trends by Regions
2.2.1 Multiplexed Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Multiplexed Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Multiplexed Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Multiplexed Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Multiplexed Diagnostics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Multiplexed Diagnostics Players by Market Size
3.1.1 Global Top Multiplexed Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Multiplexed Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global Multiplexed Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Multiplexed Diagnostics Market Concentration Ratio
3.2.1 Global Multiplexed Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Multiplexed Diagnostics Revenue in 2019
3.3 Multiplexed Diagnostics Key Players Head office and Area Served
3.4 Key Players Multiplexed Diagnostics Product Solution and Service
3.5 Date of Enter into Multiplexed Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Multiplexed Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Multiplexed Diagnostics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Multiplexed Diagnostics Market Size by Application (2015-2020)
5.2 Global Multiplexed Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Multiplexed Diagnostics Market Size (2015-2020)
6.2 Multiplexed Diagnostics Key Players in North America (2019-2020)
6.3 North America Multiplexed Diagnostics Market Size by Type (2015-2020)
6.4 North America Multiplexed Diagnostics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Multiplexed Diagnostics Market Size (2015-2020)
7.2 Multiplexed Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Multiplexed Diagnostics Market Size by Type (2015-2020)
7.4 Europe Multiplexed Diagnostics Market Size by Application (2015-2020)
8 China
8.1 China Multiplexed Diagnostics Market Size (2015-2020)
8.2 Multiplexed Diagnostics Key Players in China (2019-2020)
8.3 China Multiplexed Diagnostics Market Size by Type (2015-2020)
8.4 China Multiplexed Diagnostics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Multiplexed Diagnostics Market Size (2015-2020)
9.2 Multiplexed Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Multiplexed Diagnostics Market Size by Type (2015-2020)
9.4 Japan Multiplexed Diagnostics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Multiplexed Diagnostics Market Size (2015-2020)
10.2 Multiplexed Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Multiplexed Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Multiplexed Diagnostics Market Size by Application (2015-2020)
11 India
11.1 India Multiplexed Diagnostics Market Size (2015-2020)
11.2 Multiplexed Diagnostics Key Players in India (2019-2020)
11.3 India Multiplexed Diagnostics Market Size by Type (2015-2020)
11.4 India Multiplexed Diagnostics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Multiplexed Diagnostics Market Size (2015-2020)
12.2 Multiplexed Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Multiplexed Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Multiplexed Diagnostics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Agilent Technologies
13.1.1 Agilent Technologies Company Details
13.1.2 Agilent Technologies Business Overview
13.1.3 Agilent Technologies Multiplexed Diagnostics Introduction
13.1.4 Agilent Technologies Revenue in Multiplexed Diagnostics Business (2015-2020))
13.1.5 Agilent Technologies Recent Development
13.2 Bio-Rad Laboratories, Inc.
13.2.1 Bio-Rad Laboratories, Inc. Company Details
13.2.2 Bio-Rad Laboratories, Inc. Business Overview
13.2.3 Bio-Rad Laboratories, Inc. Multiplexed Diagnostics Introduction
13.2.4 Bio-Rad Laboratories, Inc. Revenue in Multiplexed Diagnostics Business (2015-2020)
13.2.5 Bio-Rad Laboratories, Inc. Recent Development
13.3 BioMerieux SA
13.3.1 BioMerieux SA Company Details
13.3.2 BioMerieux SA Business Overview
13.3.3 BioMerieux SA Multiplexed Diagnostics Introduction
13.3.4 BioMerieux SA Revenue in Multiplexed Diagnostics Business (2015-2020)
13.3.5 BioMerieux SA Recent Development
13.4 F. Hoffmann-La Roche Ltd.
13.4.1 F. Hoffmann-La Roche Ltd. Company Details
13.4.2 F. Hoffmann-La Roche Ltd. Business Overview
13.4.3 F. Hoffmann-La Roche Ltd. Multiplexed Diagnostics Introduction
13.4.4 F. Hoffmann-La Roche Ltd. Revenue in Multiplexed Diagnostics Business (2015-2020)
13.4.5 F. Hoffmann-La Roche Ltd. Recent Development
13.5 Illumina, Inc.
13.5.1 Illumina, Inc. Company Details
13.5.2 Illumina, Inc. Business Overview
13.5.3 Illumina, Inc. Multiplexed Diagnostics Introduction
13.5.4 Illumina, Inc. Revenue in Multiplexed Diagnostics Business (2015-2020)
13.5.5 Illumina, Inc. Recent Development
13.6 Luminex Corporation
13.6.1 Luminex Corporation Company Details
13.6.2 Luminex Corporation Business Overview
13.6.3 Luminex Corporation Multiplexed Diagnostics Introduction
13.6.4 Luminex Corporation Revenue in Multiplexed Diagnostics Business (2015-2020)
13.6.5 Luminex Corporation Recent Development
13.7 Hologic, Inc.
13.7.1 Hologic, Inc. Company Details
13.7.2 Hologic, Inc. Business Overview
13.7.3 Hologic, Inc. Multiplexed Diagnostics Introduction
13.7.4 Hologic, Inc. Revenue in Multiplexed Diagnostics Business (2015-2020)
13.7.5 Hologic, Inc. Recent Development
13.8 Thermo Fisher Scientific, Inc.
13.8.1 Thermo Fisher Scientific, Inc. Company Details
13.8.2 Thermo Fisher Scientific, Inc. Business Overview
13.8.3 Thermo Fisher Scientific, Inc. Multiplexed Diagnostics Introduction
13.8.4 Thermo Fisher Scientific, Inc. Revenue in Multiplexed Diagnostics Business (2015-2020)
13.8.5 Thermo Fisher Scientific, Inc. Recent Development
13.9 Siemens Healthineers
13.9.1 Siemens Healthineers Company Details
13.9.2 Siemens Healthineers Business Overview
13.9.3 Siemens Healthineers Multiplexed Diagnostics Introduction
13.9.4 Siemens Healthineers Revenue in Multiplexed Diagnostics Business (2015-2020)
13.9.5 Siemens Healthineers Recent Development
13.10 Abbott Laboratories
13.10.1 Abbott Laboratories Company Details
13.10.2 Abbott Laboratories Business Overview
13.10.3 Abbott Laboratories Multiplexed Diagnostics Introduction
13.10.4 Abbott Laboratories Revenue in Multiplexed Diagnostics Business (2015-2020)
13.10.5 Abbott Laboratories Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Multiplexed Diagnostics Revenue
1.4 Market by Type
1.4.1 Global Multiplexed Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Very High Density Multiplexed Assays (Above 10,000-plex)
1.4.3 High Density Multiplexed Assays (500 Below plex Below 10,000)
1.4.4 Medium Density Multiplexed Assays (plex Below 500)
1.4.5 Low Density Multiplexed Assays (plex Below 5)
1.4.6 Next Generation Sequencing Assays
1.5 Market by Application
1.5.1 Global Multiplexed Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Academic Research Institutes
1.5.3 Hospital
1.5.4 Pharmaceutical Companies
1.5.5 Clinical Research Organizations
1.5.6 Diagnostic Laboratories
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Multiplexed Diagnostics Market Perspective (2015-2026)
2.2 Global Multiplexed Diagnostics Growth Trends by Regions
2.2.1 Multiplexed Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Multiplexed Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Multiplexed Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Multiplexed Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Multiplexed Diagnostics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Multiplexed Diagnostics Players by Market Size
3.1.1 Global Top Multiplexed Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Multiplexed Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global Multiplexed Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Multiplexed Diagnostics Market Concentration Ratio
3.2.1 Global Multiplexed Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Multiplexed Diagnostics Revenue in 2019
3.3 Multiplexed Diagnostics Key Players Head office and Area Served
3.4 Key Players Multiplexed Diagnostics Product Solution and Service
3.5 Date of Enter into Multiplexed Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Multiplexed Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Multiplexed Diagnostics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Multiplexed Diagnostics Market Size by Application (2015-2020)
5.2 Global Multiplexed Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Multiplexed Diagnostics Market Size (2015-2020)
6.2 Multiplexed Diagnostics Key Players in North America (2019-2020)
6.3 North America Multiplexed Diagnostics Market Size by Type (2015-2020)
6.4 North America Multiplexed Diagnostics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Multiplexed Diagnostics Market Size (2015-2020)
7.2 Multiplexed Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Multiplexed Diagnostics Market Size by Type (2015-2020)
7.4 Europe Multiplexed Diagnostics Market Size by Application (2015-2020)
8 China
8.1 China Multiplexed Diagnostics Market Size (2015-2020)
8.2 Multiplexed Diagnostics Key Players in China (2019-2020)
8.3 China Multiplexed Diagnostics Market Size by Type (2015-2020)
8.4 China Multiplexed Diagnostics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Multiplexed Diagnostics Market Size (2015-2020)
9.2 Multiplexed Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Multiplexed Diagnostics Market Size by Type (2015-2020)
9.4 Japan Multiplexed Diagnostics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Multiplexed Diagnostics Market Size (2015-2020)
10.2 Multiplexed Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Multiplexed Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Multiplexed Diagnostics Market Size by Application (2015-2020)
11 India
11.1 India Multiplexed Diagnostics Market Size (2015-2020)
11.2 Multiplexed Diagnostics Key Players in India (2019-2020)
11.3 India Multiplexed Diagnostics Market Size by Type (2015-2020)
11.4 India Multiplexed Diagnostics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Multiplexed Diagnostics Market Size (2015-2020)
12.2 Multiplexed Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Multiplexed Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Multiplexed Diagnostics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Agilent Technologies
13.1.1 Agilent Technologies Company Details
13.1.2 Agilent Technologies Business Overview
13.1.3 Agilent Technologies Multiplexed Diagnostics Introduction
13.1.4 Agilent Technologies Revenue in Multiplexed Diagnostics Business (2015-2020))
13.1.5 Agilent Technologies Recent Development
13.2 Bio-Rad Laboratories, Inc.
13.2.1 Bio-Rad Laboratories, Inc. Company Details
13.2.2 Bio-Rad Laboratories, Inc. Business Overview
13.2.3 Bio-Rad Laboratories, Inc. Multiplexed Diagnostics Introduction
13.2.4 Bio-Rad Laboratories, Inc. Revenue in Multiplexed Diagnostics Business (2015-2020)
13.2.5 Bio-Rad Laboratories, Inc. Recent Development
13.3 BioMerieux SA
13.3.1 BioMerieux SA Company Details
13.3.2 BioMerieux SA Business Overview
13.3.3 BioMerieux SA Multiplexed Diagnostics Introduction
13.3.4 BioMerieux SA Revenue in Multiplexed Diagnostics Business (2015-2020)
13.3.5 BioMerieux SA Recent Development
13.4 F. Hoffmann-La Roche Ltd.
13.4.1 F. Hoffmann-La Roche Ltd. Company Details
13.4.2 F. Hoffmann-La Roche Ltd. Business Overview
13.4.3 F. Hoffmann-La Roche Ltd. Multiplexed Diagnostics Introduction
13.4.4 F. Hoffmann-La Roche Ltd. Revenue in Multiplexed Diagnostics Business (2015-2020)
13.4.5 F. Hoffmann-La Roche Ltd. Recent Development
13.5 Illumina, Inc.
13.5.1 Illumina, Inc. Company Details
13.5.2 Illumina, Inc. Business Overview
13.5.3 Illumina, Inc. Multiplexed Diagnostics Introduction
13.5.4 Illumina, Inc. Revenue in Multiplexed Diagnostics Business (2015-2020)
13.5.5 Illumina, Inc. Recent Development
13.6 Luminex Corporation
13.6.1 Luminex Corporation Company Details
13.6.2 Luminex Corporation Business Overview
13.6.3 Luminex Corporation Multiplexed Diagnostics Introduction
13.6.4 Luminex Corporation Revenue in Multiplexed Diagnostics Business (2015-2020)
13.6.5 Luminex Corporation Recent Development
13.7 Hologic, Inc.
13.7.1 Hologic, Inc. Company Details
13.7.2 Hologic, Inc. Business Overview
13.7.3 Hologic, Inc. Multiplexed Diagnostics Introduction
13.7.4 Hologic, Inc. Revenue in Multiplexed Diagnostics Business (2015-2020)
13.7.5 Hologic, Inc. Recent Development
13.8 Thermo Fisher Scientific, Inc.
13.8.1 Thermo Fisher Scientific, Inc. Company Details
13.8.2 Thermo Fisher Scientific, Inc. Business Overview
13.8.3 Thermo Fisher Scientific, Inc. Multiplexed Diagnostics Introduction
13.8.4 Thermo Fisher Scientific, Inc. Revenue in Multiplexed Diagnostics Business (2015-2020)
13.8.5 Thermo Fisher Scientific, Inc. Recent Development
13.9 Siemens Healthineers
13.9.1 Siemens Healthineers Company Details
13.9.2 Siemens Healthineers Business Overview
13.9.3 Siemens Healthineers Multiplexed Diagnostics Introduction
13.9.4 Siemens Healthineers Revenue in Multiplexed Diagnostics Business (2015-2020)
13.9.5 Siemens Healthineers Recent Development
13.10 Abbott Laboratories
13.10.1 Abbott Laboratories Company Details
13.10.2 Abbott Laboratories Business Overview
13.10.3 Abbott Laboratories Multiplexed Diagnostics Introduction
13.10.4 Abbott Laboratories Revenue in Multiplexed Diagnostics Business (2015-2020)
13.10.5 Abbott Laboratories Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
